Beginning August. 31, 1996 and semi-annually thereafter, Licensee will submit to The Regents a progress report covering activities by Licensee related to the development and testing of all Patent Products and obtaining governmental approvals necessary for marketing. These progress reports will be provided to The Regents to cover the progress of the research and development of the Patent Products until their first commercial sale in the United States.
Appears in 1 contract
Beginning August. 31, 1996 1997, and semi-annually thereafter, Licensee will submit to The Regents a progress report covering activities by Licensee related to the development development, including clinical trials and testing testing, of all Patent Products and the obtaining of the governmental approvals necessary for marketing. These progress reports will be provided to The Regents to cover the progress of the research and development of the Patent Products until their first commercial sale in the United States.
Appears in 1 contract
Sources: Exclusive License Agreement (Collateral Therapeutics Inc)
Beginning August. 3115, 1996 1999 and semi-annually thereafter, the Licensee will submit to The Regents a progress report covering activities by the Licensee related to the development and testing of all Patent Products and the obtaining of the governmental approvals necessary for marketingmarketing them. These progress reports will be provided to The Regents to cover the progress of the research and development of the Patent Products until their first commercial sale in the United States.
Appears in 1 contract
Sources: Exclusive License Agreement (Cytoclonal Pharmaceutics Inc /De)